CARDIFF ONCOLOGY, INC. Royalty Revenue (Deprecated 2018-01-31)
CARDIFF ONCOLOGY, INC. (CRDF) reported Royalty Revenue (Deprecated 2018-01-31) of $62.02 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Income Statement › Other Income
us-gaap:RoyaltyRevenue · last filed 2019-05-07
- CARDIFF ONCOLOGY, INC. royalty revenue (deprecated 2018-01-31) for the quarter ending 2019-03-31 was $62.02K, a 26.43% increase year-over-year.
- CARDIFF ONCOLOGY, INC. royalty revenue (deprecated 2018-01-31) for the quarter ending 2018-12-31 was $76.41K, a 34.15% decline year-over-year.
- CARDIFF ONCOLOGY, INC. royalty revenue (deprecated 2018-01-31) for the quarter ending 2018-09-30 was $72.57K, a 23.46% increase year-over-year.
- CARDIFF ONCOLOGY, INC. royalty revenue (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $52.42K, a 16.99% increase year-over-year.
- CARDIFF ONCOLOGY, INC. royalty revenue (deprecated 2018-01-31) for fiscal 2018 was $250.45K, a 12.26% decline from fiscal 2017.
- CARDIFF ONCOLOGY, INC. royalty revenue (deprecated 2018-01-31) for fiscal 2017 was $285.44K, a 10.61% increase from fiscal 2016.
- CARDIFF ONCOLOGY, INC. royalty revenue (deprecated 2018-01-31) for fiscal 2016 was $258.06K, a 6.04% decline from fiscal 2015.
- CARDIFF ONCOLOGY, INC. royalty revenue (deprecated 2018-01-31) for fiscal 2015 was $274.65K, a 1.65% increase from fiscal 2014.
| Period end | Royalty Revenue (Deprecated 2018-01-31) 3 month | Royalty Revenue (Deprecated 2018-01-31) 6 month | Royalty Revenue (Deprecated 2018-01-31) 9 month | Royalty Revenue (Deprecated 2018-01-31) 12 month | Royalty Revenue (Deprecated 2018-01-31) 152 month | Royalty Revenue (Deprecated 2018-01-31) 155 month | Royalty Revenue (Deprecated 2018-01-31) 158 month | Royalty Revenue (Deprecated 2018-01-31) 161 month | Royalty Revenue (Deprecated 2018-01-31) 164 month | Royalty Revenue (Deprecated 2018-01-31) 167 month | Royalty Revenue (Deprecated 2018-01-31) 170 month | Royalty Revenue (Deprecated 2018-01-31) 173 month | Royalty Revenue (Deprecated 2018-01-31) 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | $62.02K 10-Q · filed 2019-05-07 | $138.43K derived: sum of 2 quarters · filed 2019-05-07 | $211.00K derived: sum of 3 quarters · filed 2019-05-07 | $263.42K derived: sum of 4 quarters · filed 2019-05-07 | |||||||||
| 2018-12-31 | $76.41K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $148.97K derived: sum of 2 quarters · filed 2019-03-06 | $201.40K derived: sum of 3 quarters · filed 2019-03-06 | $250.45K 10-K · filed 2019-03-06 | |||||||||
| 2018-09-30 | $72.57K 10-Q · filed 2018-11-07 | $124.99K derived: sum of 2 quarters · filed 2018-11-07 | $174.05K 10-Q · filed 2018-11-07 | $290.07K derived: sum of 4 quarters · filed 2019-05-07 | |||||||||
| 2018-06-30 | $52.42K 10-Q · filed 2018-08-03 | $101.48K 10-Q · filed 2018-08-03 | $217.51K derived: sum of 3 quarters · filed 2019-05-07 | $276.29K derived: sum of 4 quarters · filed 2019-05-07 | |||||||||
| 2018-03-31 | $49.05K 10-Q · filed 2019-05-07 | $165.08K derived: sum of 2 quarters · filed 2019-05-07 | $223.86K derived: sum of 3 quarters · filed 2019-05-07 | $268.67K derived: sum of 4 quarters · filed 2019-05-07 | |||||||||
| 2017-12-31 | $116.03K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $174.81K derived: sum of 2 quarters · filed 2019-03-06 | $219.62K derived: sum of 3 quarters · filed 2019-03-06 | $285.44K 10-K · filed 2019-03-06 | |||||||||
| 2017-09-30 | $58.78K 10-Q · filed 2018-11-07 | $103.59K derived: sum of 2 quarters · filed 2018-11-07 | $169.41K 10-Q · filed 2018-11-07 | $219.61K derived: sum of 4 quarters · filed 2018-11-07 | |||||||||
| 2017-06-30 | $44.81K 10-Q · filed 2018-08-03 | $110.64K 10-Q · filed 2018-08-03 | $160.83K derived: sum of 3 quarters · filed 2018-08-03 | $208.06K derived: sum of 4 quarters · filed 2018-08-03 | |||||||||
| 2017-03-31 | $65.83K 10-Q · filed 2018-05-08 | $116.02K derived: sum of 2 quarters · filed 2018-05-08 | $163.25K derived: sum of 3 quarters · filed 2018-05-08 | $211.02K derived: sum of 4 quarters · filed 2018-05-08 | |||||||||
| 2016-12-31 | $50.19K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $97.43K derived: sum of 2 quarters · filed 2018-02-26 | $145.19K derived: sum of 3 quarters · filed 2018-02-26 | $258.06K 10-K · filed 2018-02-26 | |||||||||
| 2016-09-30 | $47.24K 10-Q · filed 2017-11-09 | $95.00K derived: sum of 2 quarters · filed 2017-11-09 | $207.87K 10-Q · filed 2017-11-09 | $259.59K derived: sum of 4 quarters · filed 2017-11-09 | |||||||||
| 2016-06-30 | $47.77K 10-Q · filed 2017-08-09 | $160.63K 10-Q · filed 2017-08-09 | $212.35K derived: sum of 3 quarters · filed 2017-08-09 | $263.65K derived: sum of 4 quarters · filed 2017-08-09 | |||||||||
| 2016-03-31 | $112.87K 10-Q · filed 2017-05-10 | $164.59K derived: sum of 2 quarters · filed 2017-05-10 | $215.89K derived: sum of 3 quarters · filed 2017-05-10 | $262.71K derived: sum of 4 quarters · filed 2017-05-10 | |||||||||
| 2015-12-31 | $51.72K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $103.02K derived: sum of 2 quarters · filed 2017-03-15 | $149.84K derived: sum of 3 quarters · filed 2017-03-15 | $274.65K 10-K · filed 2017-03-15 | |||||||||
| 2015-09-30 | $51.30K 10-Q · filed 2016-11-09 | $98.13K derived: sum of 2 quarters · filed 2016-11-09 | $222.93K 10-Q · filed 2016-11-09 | $279.33K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-06-30 | $46.83K 10-Q · filed 2016-08-04 | $171.63K 10-Q · filed 2016-08-04 | $228.03K derived: sum of 3 quarters · filed 2017-03-15 | $285.23K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-03-31 | $124.80K 10-Q · filed 2016-05-10 | $181.20K derived: sum of 2 quarters · filed 2017-03-15 | $238.40K derived: sum of 3 quarters · filed 2017-03-15 | $284.03K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2014-12-31 | $56.40K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $113.60K derived: sum of 2 quarters · filed 2017-03-15 | $159.22K derived: sum of 3 quarters · filed 2017-03-15 | $270.18K 10-K · filed 2017-03-15 | |||||||||
| 2014-09-30 | $57.20K 10-Q · filed 2015-11-09 | $102.83K derived: sum of 2 quarters · filed 2015-11-09 | $213.78K 10-Q · filed 2015-11-09 | $261.15K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-06-30 | $45.63K 10-Q · filed 2015-08-10 | $156.58K 10-Q · filed 2015-08-10 | $203.95K derived: sum of 3 quarters · filed 2016-03-10 | $247.70K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-03-31 | $110.95K 10-Q · filed 2015-05-05 | $158.32K derived: sum of 2 quarters · filed 2016-03-10 | $202.08K derived: sum of 3 quarters · filed 2016-03-10 | $251.08K derived: sum of 4 quarters · filed 2016-03-10 | $1.30M 10-Q · filed 2014-05-12 | ||||||||
| 2013-12-31 | $47.37K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $91.12K derived: sum of 2 quarters · filed 2016-03-10 | $140.12K derived: sum of 3 quarters · filed 2016-03-10 | $259.25K 10-K · filed 2016-03-10 | $1.18M 10-K · filed 2014-03-17 | ||||||||
| 2013-09-30 | $43.76K 10-Q · filed 2014-11-06 | $92.76K derived: sum of 2 quarters · filed 2014-11-06 | $211.88K 10-Q · filed 2014-11-06 | $270.13K derived: sum of 4 quarters · filed 2015-03-12 | $1.14M 10-Q · filed 2013-11-14 | ||||||||
| 2013-06-30 | $49.00K 10-Q · filed 2014-08-07 | $168.12K 10-Q · filed 2014-08-07 | $226.37K derived: sum of 3 quarters · filed 2015-03-12 | $267.87K derived: sum of 4 quarters · filed 2015-03-12 | $1.09M 10-Q · filed 2013-08-14 | ||||||||
| 2013-03-31 | $119.12K 10-Q · filed 2014-05-12 | $177.37K derived: sum of 2 quarters · filed 2015-03-12 | $218.87K derived: sum of 3 quarters · filed 2015-03-12 | $260.37K derived: sum of 4 quarters · filed 2015-03-12 | $1.04M 10-Q · filed 2013-05-14 | ||||||||
| 2012-12-31 | $58.25K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $99.75K derived: sum of 2 quarters · filed 2015-03-12 | $141.25K derived: sum of 3 quarters · filed 2015-03-12 | $175.40K 10-K · filed 2015-03-12 | $925.47K 10-K · filed 2013-04-01 | ||||||||
| 2012-09-30 | $41.50K 10-Q · filed 2013-11-14 | $83.00K derived: sum of 2 quarters · filed 2013-11-14 | $117.15K 10-Q · filed 2013-11-14 | $150.90K derived: sum of 4 quarters · filed 2014-03-17 | $762.22K 10-Q · filed 2012-11-14 | ||||||||
| 2012-06-30 | $41.50K 10-Q · filed 2013-08-14 | $75.65K 10-Q · filed 2013-08-14 | $109.40K derived: sum of 3 quarters · filed 2014-03-17 | $154.40K derived: sum of 4 quarters · filed 2014-03-17 | $720.72K 10-Q · filed 2012-08-14 | ||||||||
| 2012-03-31 | $34.15K 10-Q · filed 2013-05-14 | $67.90K derived: sum of 2 quarters · filed 2014-03-17 | $112.90K derived: sum of 3 quarters · filed 2014-03-17 | $192.77K derived: sum of 4 quarters · filed 2014-03-17 | $679.22K 10-Q · filed 2012-05-15 | ||||||||
| 2011-12-31 | $33.75K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $78.75K derived: sum of 2 quarters · filed 2014-03-17 | $158.61K derived: sum of 3 quarters · filed 2014-03-17 | $227.70K 10-K · filed 2014-03-17 | |||||||||
| 2011-09-30 | $45.00K 10-Q · filed 2012-11-14 | $124.86K derived: sum of 2 quarters · filed 2012-11-14 | $193.95K 10-Q · filed 2012-11-14 | ||||||||||
| 2011-06-30 | $79.86K 10-Q · filed 2012-08-14 | $148.95K 10-Q · filed 2012-08-14 | |||||||||||
| 2011-03-31 | $89.08K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |